Amedisys (AMED) Tops Q2 EPS by 53c, Revs Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Second Quarter 2020 Financial Results - Reissues 2020 Guidance
July 28, 2020 4:05 PM EDTBATON ROUGE, La., July 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2020.
Three-Month Periods Ended June 30, 2020 and 2019
Net service revenue decreased $8.0Â million to $485.0Â million compared to $493.0Â million in 2019.Net income attributable to Amedisys, Inc. of $34.7Â million compared to $33.7Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $1.04 compared to $1.02 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $66.4Â million compared to $61.4Â million in 2019.Adjusted net service revenue of $485.0Â million compared to $498.5Â million in... More